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Introduction. State of severe oxidative stress is encountered in sepsis. Paraoxonase 1 (PON1) protects against oxidative stress but
also undergoes inactivation upon that condition. We investigated PON1 activity in surgical patients with sepsis in relation to
oxidative stress status, inflammation, disease severity, and survival. Methods. Prospective observational study. Sixty-nine surgical
patients with sepsis were compared to 69 age/sex matched healthy controls. PON1 paraoxonase and diazoxonase activities, selected
biochemical, hematological and oxidative stress parameters were measured on admission to ICU and 24, 48, 72, and 96 hours later.
Disease severity scores were calculated daily. Results. Septic patients had significantly lower PON1 activities compared to control
group at all time points. PON1 activities had good capacity to differentiate septic patients fromhealthy controls. LowPON1 activities
were associated with higher disease severity scores and higher risk of death. Correlation between PON1 activity and markers of
inflammation failed to reach significance. Decrease in PON1 activity was correlated with an increase in reducing components in
plasma. Conclusion. Our study demonstrated lower PON1 activity in surgical patients with sepsis compared to healthy controls.
PON1 activity also reflected severity of the disease. Low PON1 activity was associated with higher mortality of surgical patients
with sepsis.
1. Introduction
Immune response in sepsis increases production of reactive
oxygen and nitrogen species [1]. If production of these
reactive species exceeds organism’s ability to detoxify the
reactive intermediates or to repair the resulting damage, a
state of oxidative stress occurs. A number of studies describe
oxidative stress in patients with sepsis with evidence of
depleted antioxidant defense [2].
Paraoxonase 1 (PON1) is a calcium-dependent esterase
mainly synthesized by the liver [3]. PON1 peroxidase
and esterase activities seem to be of major importance in
detoxifying oxidative stress mediators which probably
explains the antioxidant and anti-inflammatory potential of
the enzyme [4]. Growing interest in the enzyme’s importance
is prompted by its role in lipid peroxidation and the
development of atherosclerosis [5]. Decreased PON1 activity
was also observed in liver disease [6, 7], acute pancreatitis
[8], diabetes [9], chronic renal failure, and dialysis [10, 11]. So
far, no data have been reported on the utility of serial PON1
measurement in surgical patients with sepsis.
The objective of this study was to investigate PON1
activity in surgical patients with sepsis in relation to disease
severity, oxidative stress status, inflammation, and survival.
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2. Materials and Methods
2.1. Patients. This prospective, observational study included
69 patients (36 men/33 women, age 62.0 (54.5–74.0) years)
admitted to university hospital surgical intensive care unit
(ICU) for treatment of sepsis during 2011. Sepsis was
diagnosed according to American College of Chest Physi-
cians/Society of Critical Care Medicine Consensus Confer-
ence criteria [12]. Patients with chemotherapy and radio-
therapy in the past 30 days, immunosuppressant therapy,
major trauma, end-stage organ disease, cardiogenic, or hem-
orrhagic shockwere excluded. Acute Physiology andChronic
Health Evaluation II score (APACHE II) [13] and Sequential
Organ Failure Assessment score (SOFA) [14] were calcu-
lated daily. Data regarding mechanical ventilation, inotropic
and/or vasopressor support, and survival were obtained from
medical records.
Control group consisted of 69 age and sex-matched
healthy patients (36men/33women, age 61 (54.5–69.0) years),
who attended annual medical checkups at health centers in
Belgrade, were free of known cardiac, renal, and hepatic
diseases and were not taking any prescribed medication.
There was no statistically significant difference in age and
gender between these groups. The study was approved by
institutional ethical committee andwritten informed consent
obtained from participants or their legal representatives.
2.2. Samples. Venous blood samples frompatientswith sepsis
were collected during the first hour following admission to
ICU (0 h) and 24 h, 48 h, 72 h, and 96 h later. Samples from
control group were collected in the morning, after fasting for
the night. Blood was drawn into standard collection tubes
with cloth activator. Centrifuged serum aliquots used for
measurement of PON1 and oxidative stress parameters were
frozen to −20∘C and stored to −80∘C until analysis. Other
parameters were analyzed on the day of collection. Lactate
levels were measured in arterial blood samples.
2.3. PON1 Activities and Oxidative Stress Parameters. Serum
paraoxonase-1 (PON1) activity was measured as rate of
paraoxon (POase) and diazoxone (DZOase) hydrolysis
according to Richter and Furlong [15]. Malondialdehyde
(MDA), a marker of lipid peroxidation, was measured using
thiobarbituric acid reactive substancesmethod [16]. A colori-
metric assay based on the oxidation of ferrous ion to ferric ion
in the presence of various oxidant species in acidic medium
was used for total oxidant status (TOS) measurement [17].
Total antioxidant status (TAS) was determined with novel
automated colorimetric method developed by Erel [18].
The assay used for measurement of prooxidant-antioxidant
balance (PAB) is based on 3,3󸀠,5,5󸀠-tetramethylbenzidine and
its cation used as a redox indicator participating in two
simultaneous reactions [19].
2.4. Biomarkers of Inflammation and Infection. White blood
cells (WBC) count was measured in hematology analyzers
(ABX Horiba, Pentra DX 120, Montpellier, France and Beck-
man Coulter, AcT diff, Germany). Immunoturbidimetric
assay (bioMerieux, Lion, France on the IL 650 analyzer,
Milan, Italy) was employed for C reactive protein (CRP)
concentrationmeasurement. Serumprocalcitonin (PCT)was
measured with ELFA method (bioMerieux, Lion, France).
With this method, a concentration >2 𝜇g/L represents high
risk of severe sepsis and/or septic shock.
2.5. Biochemical Parameters. Serum urea, creatinine, and
total bilirubin concentrations; aspartate-aminotransferase
(AST); and alanine-aminotransferase (ALT) activities were
analyzed employing routine methods (Instrumentation Lab-
oratory reagents using the analyzer IL 650, Milan, Italy).
Lactate level was measured by blood gas analyzer (GEM
Premier 3000, Instrumentation Laboratory, Milan, Italy).
2.6. Statistical Analysis. Statistical analysis was performed in
SPSS 15.0 software (SPSS Inc., Chicago, IL, USA). Normality
of data was assessed with Shapiro-Wilk test. Data were pre-
sented asmedian and 25th to 75th quartile. Friedman test was
used to calculate significance of difference in multiple related
samples andMann-Whitney𝑈 test in nonrelated samples. To
determine possible correlation between variables in patients
with sepsis, Kendall tau-b test was employed. Areas under
receiver operating characteristic curves (AUC-ROC) were
also calculated. Kaplan-Meier survival analysis and stepwise
multiple linear regression analysis were performed. The
minimal statistical significance was set at two-tailed𝑃 < 0.05.
3. Results
On admission to ICU, 36 of 69 patients had uncompli-
cated sepsis, 23 severe sepsis and 10 were in septic shock.
General characteristics, PON1 activities, oxidative stress, and
biochemical parameters of the study groups were listed in
Table 1. Septic patients had significantly lower POase and
DZOase activities compared to control group at all time
points. PON1 activities did not changed significantly during
first five days in ICU (Friedman 𝑝POase = 0.302, 𝑝DZOase =
0.982). State of exacerbated oxidative stress was evidenced
through significantly higher TOS, PAB, and MDA levels and
lower TAS levels compared to the control group. Oxidative
stress parameters in patients with sepsis also did not change
significantly for the duration of the study (Friedman 𝑝TAS =
0.275, 𝑝TOS = 0.507, 𝑝PAB = 0.598, and 𝑝MDA = 0.683).
AUC-ROC was used to evaluate PON1 activities on
admission to ICU as a marker of sepsis (Figure 1). AUC-ROC
for POase was 0.856 (95% CI: 0.777 to 0.934), 𝑃 < 0.001
and 0.921 (95% CI: 0.857 to 0.984), 𝑃 < 0.001 for DZOase.
PON1 activities on admission to ICU had good to excellent
capacity to differentiate surgical patients with sepsis from
healthy controls.
We found significant positive correlation between POase
and DZOase PON1 activities (Table 2). Both POase and
DZOase activity positively correlated with calcium concen-
tration (𝜏 = 0.271, 𝑃 < 0.01 and 𝜏 = 0.237, 𝑃 <
0.05, resp.). A trend towards negative correlation between
PON1 activities and markers of inflammation and infection























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2: Correlation coefficients between listed parameters in surgical patients with sepsis.
Kendal 𝜏
𝐵
POase DZOase TAS TOS PAB MDA
POase 1.000 0.243∗∗ −0.033 0.160∗∗ 0.140∗∗ −0.104
DZOase 0.243∗∗ 1.000 −0.034 0.080 0.020 −0.026
WBC −0.056 −0.063 0.008 −0.004 −0.016 −0.071
CRP −0.065 −0.098 0.022 −0.004 0.025 0.171∗
PCT 0.037 0.043 0.227∗∗ −0.022 −0.350∗∗ 0.182∗
APACHE II −0.185∗∗ −0.081 0.235∗∗ −0.191∗∗ −0.402∗∗ 0.182∗∗
SOFA −0.111 −0.232∗ 0.176∗ −0.127 −0.422∗∗ 0.189∗
Urea −0.096 −0.107 0.309∗∗ 0.209∗∗ −0.401∗∗ 0.234∗∗
Creatinine −0.077 −0.017 0.319∗∗ −0.174∗∗ −0.419∗∗ 0.202∗∗
Bilirubin 0.020 −0.013 0.176∗ −0.047 −0.241∗∗ 0.439∗∗
AST 0.098 0.107 0.188∗∗ −0.011 −0.314∗∗ 0.323∗∗
ALT 0.202∗∗ 0.096 0.163∗ 0.062 −0.136∗ 0.256∗∗
Lactate −0.179∗∗ −0.049 0.118 −0.010 −0.205∗∗ 0.125
∗
𝑃 < 0.05 (2-tailed); ∗∗𝑃 < 0.01 (2-tailed). Kendal tau b correlation analysis. TAS: total antioxidant status; TOS: total oxidant status; PAB:
prooxidant-antioxidant balance; MDA: malondialdehyde; APACHE II: Acute Physiology and Chronic Health Evaluation II score; SOFA: Sequential Organ
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Figure 1: Relevance of POase and DZOase activity on admission to
ICU as biomarkers of sepsis. AUC-ROCPOase 0.856 (95% CI: 0.777–
0.934) 𝑃 < 0.001, AUC-ROCDZOase 0.921 (95% CI: 0.857–0.984) 𝑃 <
0.001. AUC-ROC (area under the receiver operating characteristic
curve). Red line-POase; blue line-DZOase.
and disease severity scores were inversely correlated. In
fact, multiple linear regression analysis revealed that SOFA
score was independent predictor of both POase and DZOase
activity (standardized coefficient 𝛽 = −0.328; 𝑃 = 0.012 and
𝛽 = −0.317; 𝑃 = 0.034, resp.). POase activity correlated
negatively with lactate levels but not with markers of renal
and liver function.
Unexpectedly, POase activity correlated positively with
TOS and PAB. These parameters were included in stepwise
multiple linear regression analysis and PAB proved to be a
positive predictor of POase activity (standardized coefficient
𝛽 = 0.304; 𝑃 = 0.004). MDA, a marker of oxidative stress,
correlated positivelywithmarkers of inflammation, infection,
and renal and liver function as well as disease severity scores.
Surprisingly, it correlated positively with TAS (𝜏 = 0.172,
𝑃 < 0.01) and negatively with PAB (𝜏 = −0.226, 𝑃 < 0.01).
TAS correlated positively and TOS and PAB negatively with
PCT values, markers of renal and liver function, and disease
severity scores. Further analysis included serum creatinine,
bilirubin, and PCT levels as potential predictors of oxidative
stress parameters. We found that creatinine and bilirubin
levels were significant predictors of MDA concentration
(standardized coefficients 𝛽creatinine = 0.394, 𝑃 < 0.001 and
𝛽bilirubin = 0.469, 𝑃 < 0.001). Serum creatinine was the only
predictor of TAS (standardized coefficients 𝛽creatinine = 0.401,
𝑃 < 0.001). All three parameters were negative predictors of
PAB (standardized coefficients 𝛽creatinine = −0.362,𝑃 < 0.001;
𝛽PCT = −0.284, 𝑃 = 0.004 and 𝛽bilirubin = −0.189, 𝑃 = 0.040).
These parameters were not good predictors of TOS, but after
substituting creatinine with urea in this model, we found that
urea and PCT levels could predict TOS (standardized coeffi-
cients 𝛽urea = −0.451, 𝑃 < 0.001; 𝛽PCT = −0.239, 𝑃 = 0.017).
Twenty-six of 69 patients died while treated for sepsis,
37 required mechanical ventilation and 26 inotropic and/or
vasopressor support. Figure 2 presents PON1 activities in
patients with sepsis based on survival, mechanical ven-
tilation, and use of inotropic and/or vasopressors, RRT.
We observed a trend towards lower POase and DZOase
activity in nonsurvivors, mechanically ventilated patients,
and in patients requiring inotropic and/or vasopressors. This
difference reached statistical significance on admission to
ICU and 48 h later. DZOase activities were not statistically
different between these groups of septic patients.
Kaplan-Meier survival analysis presented in Figure 3
clearly shows higher risk of death with lower POase activity
(log rank 𝑃 < 0.001), while DZOase activity did not seem to
be a good predictor of sepsis outcome (log rank 𝑃 = 0.075).
Surprisingly, higher TAS andMDAvalues as well as lower























































Figure 2: POase activities in patients with sepsis based on survival, mechanical ventilation, use of inotropes, and/or vasopressors. (a)
Survivors versus nonsurvivors; (b) mechanically ventilated versus not mechanically ventilated; (c) inotropes and/or vasopressors versus no
inotropes and/or vasopressors. Data are presented as medians. ∗
𝑃
< 0.05—Mann-Whitney 𝑈 test.
rank 𝑝TAS = 0.016, 𝑝MDA = 0.002, 𝑝TOS = 0.002, and 𝑝PAB <
0.001).
4. Discussion
Despite considerable interest in the research of PON1 activity
in various acute and chronic diseases, importance of PON1 in
critical illness is just starting to be explored. Serum PON1 has
been demonstrated in multiple clinical and animal studies to
protect against oxidative stress but also to undergo inactiva-
tion upon that condition [4, 5]. Previous studies showed low
PON1 activity in small groups of medical patients with sepsis
compared to healthy controls [20–22]. We have also found
that both POase and DZOase activity were lower in surgical
patients with sepsis than in healthy controls. In the study
of Sans et al., POase activity significantly decreased between
admission to ICU and the following day but remained
unchanged for the next 4 days [21]. In our study, low PON1
activity did not significantly change during first 5 days of
disease. PON1 activity also reflected severity of the disease.
In our study PON1 activities were lower in patients with


































Figure 3: Kaplan-Meier estimates of 14-day survival in patients stratified in (a) POase activity quartiles and (b) DZOase activity quartiles.
Log rank: (a) POase 𝑃 < 0.001 and (b) DZOase 𝑃 = 0.075. Black line—4th quartile; blue line—3rd quartile; green line—2nd quartile; red
line—1st quartile.
with results from Novak et al. who did not find statistically
significant correlation between PON1 activities and disease
severity scores [20], while Sans et al. found this correlation to
be significant only after recovery from sepsis [21].
A ROC curve analysis showed both POase and DZOase
activities to be good to excellent markers of sepsis. To
date, similar evaluation of POase and DZOase activities
as diagnostic tests for sepsis was not performed. However,
measurement of PON1 arylesterase activity was found to be
an efficient test for identifying the presence and severity of
chronic liver injury [6].
In this study, septic patients had increased prooxidant
and decreased antioxidant status compared to control group
implicating state of severe oxidative stress. Surprisingly,
higher disease severity scores followed by decrease in PON1
activity were associated with better antioxidant and worse
prooxidant status. Chuang et al. also demonstrated positive
correlation between total antioxidant capacity and APACHE
II score [23]. A possible explanation for this phenomenon
could be found in relationship between these parameters
and serum creatinine and bilirubin, known reducing type
antioxidants [24, 25]. In our study, TAS and MDA correlated
positively and TOS and PABnegatively with serum creatinine
and bilirubin levels. Moreover, creatinine and bilirubin levels
could actually predict oxidative status parameters values.
One could argue that increase in creatinine and bilirubin
concentrations, caused by renal and hepatic dysfunction, is
at least partially responsible for increase in antioxidant and,
consequently, decrease in prooxidant status measurement. At
the same time, comparison to healthy controls clearly shows
that septic patients actually were in a state of severe oxidative
stress and had impaired antioxidant defense.
We found no significant correlation between markers of
inflammation and PON1 activity. Various research groups
have demonstrated that inflammationmodulates PON1 activ-
ity [5]. Association between CPR and PON1 values in sepsis
was observed by Novak et al. [20] but not by Sans et al. [21].
In our study, serum PON1 activities were significantly
lower in nonsurvivors than in survivors. Furthermore, lower
PON1 activities were associated with higher mortality as pre-
viously implicated byDraganov et al. [22]. On the other hand,
Novak et al. foundno significant difference between survivors
and nonsurvivors, but a trend toward lower arylesterase
PON1 activity in nonsurvivors as compared to survivors
was noticed [20]. Low PON1 activity is also associated with
breast cancer mortality [26] and certain genotypes of PON1
gene with lung carcinoma [27]. Lower PON1 activities were
also observed in patient requiring mechanical ventilation
or inotropes and/or vasopressors. So far, no studies were
performed to explore association between these measures of
vital support and PON1 activity.
Relatively small and diverse group of patients was the
biggest drawback of our study. Further studies are needed to
fully investigate role of PON1 in pathogenesis of sepsis.
5. Conclusion
This study demonstrated significantly lower PON1 activity in
surgical patients with sepsis than in healthy controls. Low
PON1 activity was associated with higher disease severity
scores and higher risk of death. Decrease in PON1 activity
was associated with better antioxidant and worse prooxidant
status. Correlation between PON1 activity and markers of
inflammation was not observed.
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